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Background: The prevalence of type 2 diabetes is rising worldwide, as has been the global mean fasting plasma
glucose level. This study aimed to evaluate the effectiveness of a structured individual-based lifestyle education
(SILE) program to reduce the hemoglobin A1c (HbA1c) level in type 2 diabetes patients delivered by registered
dietitians in primary care clinical settings.
Methods: This was a 6-month prospective cluster randomized controlled trial in a primary care setting with
randomization at the practice level. Twenty general practitioners in 20 clinics in Kanagawa prefecture, Japan, were
involved. 193 adults (51% men, mean age 61.3 years) with type 2 diabetes and HbA1c ≥6.5% who received
treatment in medical clinics were the participants. A SILE program was implemented through 4 sessions with
trained registered dietitians during the 6-month study period. Results were compared with those of a control group
who received usual care. The primary endpoint was the change in HbA1c levels at 6 months from baseline.
Secondary endpoints were the changes at 6 months from baseline in fasting plasma glucose, lipid profile, blood
pressure, BMI, energy, and nutrient intakes (whole day and each meal). Intention-to-treat analysis was conducted.
Mixed-effects linear models were used to examine the effects of the treatment.
Results: The mean change at 6 months from baseline in HbA1c was a 0.7% decrease in the intervention group
(n = 100) and a 0.2% decrease in the control group (n = 93) (difference −0.5%, 95%CI: -0.2% to −0.8%, p = 0.004). After
adjusting for baseline values and other factors, the difference was still significant (p = 0.003 ~ 0.011). The intervention
group had a significantly greater decrease in mean energy intake at dinner compared with the control group and a
greater increase in mean vegetable intake for the whole day, breakfast, and lunch as shown in crude and adjusted
models. A tendency toward improvement was observed in the other secondary endpoints but the improvement was
not statistically significant. These results were confirmed by several sensitivity analyses.
Conclusions: The SILE program that was provided in primary care settings for patients with type 2 diabetes resulted in
greater improvement in HbA1c levels than usual diabetes care and education.
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The prevalence of type 2 diabetes is rising worldwide, as
has been the global mean fasting plasma glucose (FPG)
level [1]. Type 2 diabetes is associated with serious com-
plications such as blindness and renal failure, as well as
an increased risk of cardiovascular disease [2]. Type 2
diabetes is responsible for a disproportionate use of health
service resources, and its increased prevalence presents
a serious problem from the viewpoint of medical eco-
nomics. In Japan, approximately 8.9 million people are
estimated to have diabetes based on a hemoglobin A1c
(HbA1c) level of 6.5% (NGSP) or over or receiving treat-
ment for type 2 diabetes [3]. Lifestyle modification is
the cornerstone of treatment for people with type 2 dia-
betes. Little evidence of benefit exists for nutritional
education in patients with type 2 diabetes in clinics in
community medicine settings. Lack of a useful tool to
assess dietary intake and difficulty in continuous man-
agement of a patient’s lifestyle may be related to this.
Meta-analyses of randomized controlled trials (RCTs)
have shown that lifestyle interventions improved gly-
cemic control with type 2 diabetes patients [4]. Although
several types of lifestyle education programs have been
proposed, reports of their effectiveness in Asian popula-
tions, including Japanese populations, have been scant
[5,6]. Considering that a frequent feature of type 2 dia-
betes in Japan is not obesity, dietary education that fo-
cuses on the pattern of eating to improve the HbA1c
level by controlling the postprandial rise in plasma glu-
cose and by improving the fasting plasma glucose level
is important. Namely, modifying energy intake at dinner
and increasing vegetable intake at breakfast and lunch
should be effective. The rationale for this strategy is based
on the following: 1) proper energy intake at dinner is
important since night-time activity is less than day-time
activity considering circadian rhythms [7]; 2) a meal with
increased dietary fiber can control the postprandial rise
in the plasma glucose level and contribute to the improve-
ment in HbA1c [8]; and 3) to increase vegetable intake
at breakfast and lunch is required because vegetable
intake at these meals is usually less than at dinner.
Therefore, to conduct effective dietary education, an
appropriate assessment of nutritional intake at each meal
is important.
A food frequency questionnaire (FFQ) is a feasible method
for this purpose, and we developed a FFQ consisting of a
list of 82 foods (FFQW82) [9]. Using the FFQW82, we
have recently developed a structured individual-based life-
style education (SILE) program to be used in clinics that
aims to modify dietary intake at breakfast, lunch, and
dinner and that is focused on behavior assessment, goal-
setting, problem-solving, and provision of tailored infor-
mation from registered dietitians. The main current
recommendations for individuals with diabetes by theJapan Diabetes Society (JDS) [10] related to energy in-
take are calculated using the ideal body weight and
three levels of physical activity. The proportion of total
energy intake from carbohydrate is recommended to
be 50 ~ 60% and from total fat less than 25%, from
saturated fatty acid less than 7%, and from polyunsat-
urated fatty acid less than 10%. Intakes of protein, fiber,
and salt are recommended to be 1.0 ~ 1.2 g/kg/day, 20 ~
25 g/day, and less than 10 g/day, respectively. Our SILE
program basically follows the guidelines of the JDS with
the additional recommendation to reduce energy intake
at dinner and increase vegetable intake at breakfast and
lunch, which should be a more practical strategy than
the JDS recommendations.
The aim of this study was to examine the effect of life-
style education using the SILE program provided by reg-
istered dietitians for type 2 diabetes patients in primary
care clinics by assessing changes in HbA1c levels, other
clinical data and dietary intakes. Results will provide
useful information for not only Japanese type 2 diabetes
patients but also for type 2 diabetes patients in other
Asian countries and for patients in Western countries
who have already modified their dietary intake to some
extent, although still insufficiently, or who have failed
with regard to weight control in many instances.
Methods
Study design
This was a 6-month cluster randomized controlled trial
with two intervention arms performed between September
2007 and June 2011 inclusive at clinics in Kanagawa pre-
fecture, Japan. Details of the study design and calculation
of the sample size were published previously [11], with
only a brief description shown below. The study was
approved by the Medical Ethical Committee of the
National Institute of Public Health in Japan in 2006
(NO. NIPH-IBRA #06005).
Participants
Volunteer general practitioners who agreed with our study
purposes and procedures were recruited. We randomly
assigned in turn a general practitioner representing a pri-
mary care clinic to either the intervention group (IG) or
control group (CG) with the use of a randomization list
(random permutated blocks with block size 2). Participat-
ing general practitioners in each primary care clinic exam-
ined the study patients themselves. 20 clinics were finally
randomized to either the IG or CG. Participating general
practitioners were encouraged to continuously recruit all
eligible study patients from September 2007 to the end of
December 2010. Each general practitioner was asked to
recruit no fewer than 10 patients, if possible, but no more
than 13 who satisfied the criteria for eligibility to partici-
pate in the study. Our study protocol called for 10 patients
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7–13 patients per clinic. The higher number was allowed
to maintain statistical power in the event of dropouts
and the lower number was permitted in clinics where in
10 patients could not be enrolled.
Study participants were men and women from 20 to
79 years of age with type 2 diabetes and HbA1c concen-
trations of 6.5% (NGSP) or over and who were receiving
treatment by the assigned general practitioner in the
primary care clinic. The value for HbA1c (%) was esti-
mated as a National Glycohemoglobin Standardization
Program (NGSP) equivalent value (%) calculated by the
formula HbA1c (%) = HbA1c Japan Diabetes Society (JDS)
(%) + 0.4%, considering the relational expression of HbA1c
(JDS) (%) measured by the previous Japanese standard
substance and measurement methods and HbA1c (NGSP)
[12]. Therefore, 6.5% (NGSP in the protocol paper [11]) is
equivalent to 6.1% (JDS in this paper).
Intervention and control groups
The IG received structured individual-based lifestyle
education that mainly encouraged the reduction in en-
ergy intake at dinner and an increase in vegetable intake
at breakfast and lunch. Support for self-management of
glycemic control, such as by diet, exercise, and stress man-
agement, was provided in 3 or 4 sessions with trained reg-
istered dietitians during the study period. The program
for the IG was structured in four steps: “Basic informa-
tion on glycemic control”, “Actions for glycemic control”,
“Daily activities for glycemic control”, and “Management
of stress for glycemic control”. We developed this pro-
gram based on some of the strategies described in previ-
ous studies [13-15]. An assessment sheet, which was
developed by consulting evidence-based practice guide-
lines for treatment of diabetes in Japan [15], was used.
Patients decided on one or two short-term goals for gly-
cemic control to be achieved in the next month based
on the results of the FFQW82 and advice by registered
dietitians. Sedentary participants were encouraged to
increase basal physical activity. We recommended a grad-
ual increase in physical activity in daily life rather than a
formal fitness regimen or sports activity during leisure
time. Before the start of the study, registered dietitians
had the opportunity to gain experience with the interven-
tion protocol under supervision by the project team.
Patients in the CG received information on dietary
intake estimated using the FFQW82 and general advice
on glycemic control by registered dietitians. A consult-
ation by a dietitian was provided once with a month of
randomization. The general advice was that which was
usually given for glycemic control usually given by a
general practitioner or a nurse in a clinic, such as “don’t
eat too much eat at dinner”, “eat more vegetables”, “do
exercise”, and so on. As for clinics without dietitians(11 clinics; 6 for IG, 5 for CG), registered dietitians were
randomly allocated. Four registered dietitians visited more
than one of these clinics. Training of registered dietitians
was conducted based on an instruction manual and thus
did not differ between those at the intervention clinics
and control clinics.
Study hypothesis
The hypothesis underlying the study is that participation
in the IG would decrease the HbA1c level by 15% from
baseline (primary endpoint) after 6 months whereas we
assumed that such a decrease would not occur in the
CG. The value of a 15% decrease in the HbA1c level was
decided through reference to materials published in the
USA [13] and through our experience with a previous
survey [16].
Outcome measures
The primary endpoint was a change from the baseline
HbA1c level after 6 months of education. Secondary end-
points were changes at 6 months from baseline in other
clinical data such as body mass index (BMI), blood pres-
sure, fasting plasma glucose (FPG), and the lipid profiles
(low density lipoprotein [LDL], high density lipoprotein
[HDL], triglycerides [TG]). Dietary intakes were
assessed using the FFQW82. Energy and vegetable in-
takes (whole day and each meal) and dietry fiber intake
(whole day), proportions of carbohydrate, protein, and
fat to total energy intakes were examined as secondary
endpoints.
Measurements were made at baseline, at 3 months,
and at 6 months (endpoint). However, because the changes
in the endpoints between the IG and CG were the effect
sizes in the present study, we used the measures at 3
months only for the last observation carried forward
(LOCF) analysis.
All clinical data were obtained by general practitioners
in the course of their usual clinical practice and by their
generally used methods. We then extracted these data
from their medical records. Our protocol stated that waist
circumference would be a secondary outcome measure,
but waist circumference measurements were missing for
some patients, and there appeared to be large variations
in the measurements for some individuals. Thus we elimi-
nated waist circumference from the analysis. We assessed
physical activity levels at baseline and at 6 months using
the question “How frequently do you engage in physical
activity or aerobic exercise such as walking, swimming,
physical training, etc. for 10 minutes or more in a week?”
The response was classified into 3 levels: “none”, “1-3
day(s) per week”, and “4 days or more per week”. Because
the SILE program concentrated on dietary modifications,
we used the levels of physical activity at baseline as an
adjusted variable in the multivariate adjusted model
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affect outcomes. We added such changes in the multi-
variate adjusted model (Model 4).Statistical analysis
Pearson correlation coefficients for changes in outcome
measures were obtained.
Intention-to-treat (ITT) analysis was conducted. The
LOCF method and a multiple imputation (MI) method
using chained equations under the assumption of missing
at random (MAR) [17] were used for handling missing
data. Per-protocol analysis (PPA) with the complete data
set (CDS) was conducted as a sensitivity analysis. Mixed-
effects linear models were used to examine the effects of
the treatment and cluster effect. Namely, in order to assess
within-clinic (S2w) and between-clinic (S
2
b) variances, mixed-
effects linear models were used, which included a crude
model (Model 1), a baseline-adjusted model (Model 2),
baseline, gender, age, and BMI-adjusted model (Model 3),
and multivariate-adjusted (gender, age, BMI, smoking habit,
baseline and change in physical activity level, family history
of type 2 diabetes, and complications) model (Model 4)
using individual data.
A significance level of 5% (two sided) was used for
all tests. All statistical analyses were performed using
SAS version 9.2 for Windows (SAS Institute, Inc., Cary,
NC, USA).Figure 1 Flow diagram of progress of clusters and individuals througResults
Following the guidelines of CONSORT [18], Figure 1
shows a flow diagram of progress of the clusters and indi-
viduals through phases of the randomized trial. In total,
20 clinics were randomized to either the IG (10 clinics) or
CG (10 clinics), and 215 patients (113 IG, 102 CG) were
recruited. Eleven patients (5 IG, 6 CG) did not meet the
inclusion criteria and 11 patients (8 IG, 3 CG) could not
complete the FFQW82. Finally, 193 patients were deemed
eligible and assigned to their respective groups (100 IG;
93 CG) according to the allocation of the clinic where
they received treatment. Therefore 193 patients were used
for ITT analysis. During the study, 39 patients discontinued
participation because they had left the area, changed clinics,
became hospitalized, increased dosage or changed hypogly-
cemic agents, started or changed dosage of insulin, refused
to continue, or could no longer be contacted (see Figure 1).
Thus, PPA included 154 patients (84 [80%] IG, 70 [75%]
CG). The background characteristics of participants in the
IG and CG are shown in Table 1. Overall mean age was
61.3 years (60.4 years IG, 62.3 years CG). Table 2 shows
baseline and 6-month follow-up statistics on the outcome
measures in both study groups.
The 6-month ITT/LOCF analysis showed a significantly
greater mean change in HbA1c from baseline (95% con-
fidence interval) in the IG compared with the CG: -0.7%
vs. -0.2%; difference −0.5% (−0.8% to −0.2%), p = 0.004
(Model 1). Those values for the baseline adjusted analysish phases of the randomized trial.
Table 1 Background characteristics of patients with type 2 diabetes allocated to intervention group or control group
Intervention group (n = 100) Control group (n = 93)
Age (yr) 60.4 (11.4) 62.3 (10.1)
Women 55 (55%) 54 (58%)
Smoking status
Not smoking 88 (88%) 78 (84%)
Current smoking 12 (12%) 13 (14%)
Past smoking 0 (0%) 2 (2%)
Family history of type 2 diabetes
Having 49 (49%) 34 (37%)
Not having 46 (46%) 48 (52%)
Unknown 5 (5%) 11 (12%)
Complications$
None 14 (14%) 12 (12%)
Hypertension 59 (59%) 56 (60%)
Dyslipidemia 21 (21%) 22 (24%)
Diabetes treatment
Diet only 36 (36%) 31 (33%)
Oral hypoglycemic only 54 (54%) 50 (54%)
Insulin and oral hypoglycemic 5 (5%) 5 (5%)
Insulin only 5 (5%) 7 (8%)
Other Medication$
None 25 (25%) 39 (42%)
Antihypertensive 60 (60%) 39 (42%)
Lipid modifying 46 (46%) 33 (35%)
Data are mean (SD) or number (%).
$ multiple responses.
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p = 0.004 (Model 2). Significant improvements were
also shown for gender, age, and BMI adjusted analysis
(Model 3) (p = 0.003) and for multivariate-adjusted ana-
lysis (Model 4) (p = 0.011). Further analyses of the HbA1c
level with PPA/CDS and MI method showed similar sig-
nificant effects. A tendency toward improvement was
observed but the improvement was not statistically sig-
nificant for the other clinical outcome measures, such
as BMI, FPG, systolic blood pressure, diastolic blood
pressure, LDL, HDL, and TG (Table 3.) Because FPG,
HDL, and TG included many missing data and showed
a large variance, the MI solutions were not converged
and the estimates by the MI method for those were
not obtained.
Larger energy intake at dinner (r = 0.29, p = 0.001) and
larger fat intake at dinner (r = 0.17, p = 0.055) were cor-
related with an increase in the HbA1c level whereas larger
vegetable intake at breakfast (r = −0.21, p = 0.015) and for
the whole day (r = −0.18, p = 0.042) were correlated with
reductions in the HbA1c level. Increases in BMI (r = 0.28,
p < 0.001), FPG (0.47, p < 0.001), LDL (r = 0.22, p = 0.011),
and TG (r = 0.34, p < 0.001) were correlated with increasesin HbA1c. This suggests that the changes between end-
points were moderately correlated with each other.
Results of the analyses for dietary outcomes are sum-
marized in Table 4. There was a statistically significant
difference at 6 months from baseline in energy intake at
dinner in the IG compared with the CG when all models
were used for both the ITT/LOCF and PPA/CDS ana-
lyses, but not MI method (Table 4). There was a statisti-
cally significant mean change at 6 months from baseline
between groups in vegetable intake for a whole day,
breakfast, and lunch (p = 0.000 ~ 0.043 for Model 1 to
Model 3) (Figure 2). Specifically, intake of vegetables in
the IG was significantly greater than in the CG for a
whole day breakfast and lunch. For dietary fiber intake,
a statistically significant increase was shown only for
Model 1 and Model 2 by ITT/LOCF. No statistically
significant changes were shown for the other nutrient
outcomes such as proportions of carbohydrate, protein,
and total fat of total energy.
Discussion
This 6-month cluster randomized controlled trial to
assess the effectiveness of a structured individualized
Table 2 Baseline and at 6th months clinical and dietary characteristics
Intervention group (n = 100) Control group (n = 93)
Baseline at 6th months Baseline at 6th months
Characteristics n Mean SD* n Mean SD* n Mean SD* n Mean SD*
HbA1c (%)
# 100 7.6 1.4 84 6.7 1.2 93 7.3 1.1 70 7.0 1.0
BMI (kg/m2) 100 26.3 4.6 91 25.6 4.3 93 24.9 4.6 82 24.5 4.4
Fasting plasma glucose (mg/dl) 79 174 70 78 145 63 77 160 71 66 134 48
Systolic blood pressure (mmHg) 100 133 17 85 132 15 93 132 17 81 130 16
Diastolic blood pressure (mmHg) 100 78 12 84 77 11 93 75 12 81 72 11
LDL cholesterol (mg/dl) 96 127 29 87 121 29 89 122 30 71 122 28
HDL cholesterol l (mg/dl) 87 56 16 80 58 20 88 56 13 68 59 15
Triglycerides (mg/dl) 84 151 84 78 135 104 77 141 74 69 133 70
Energy intakes
Whole day (kcal) 100 1686 272 80 1624 220 93 1671 238 68 1655 259
Breakfast (kcal) 100 412 161 80 423 137 93 403 151 68 401 149
Lunch (kcal) 100 551 159 80 535 130 93 551 125 68 540 143
Dinner (kcal) 100 741 100 80 700 91 93 732 95 68 726 99
Proportion of carbohydrate (%) 100 55.3 2.5 80 55.2 2.4 93 55.1 2.9 68 54.6 4.2
Proportion of protein (%) 100 15.9 1.3 80 16.1 0.8 93 16.0 1.0 68 16.3 1.5
Proportion of fat (%) 100 28.8 2.0 80 28.7 2.0 93 28.9 2.3 68 29.2 3.1
Fiber intake (g) 100 12.1 2.3 80 12.8 2.1 93 12.6 2.1 68 12.7 2.5
Vegetable intakes
Whole day (g) 100 196.5 [155, 242] 80 236.5 [202.0, 281.5] 93 223.0 [183, 275] 68 208.5 [175, 263.5]
Breakfast (g) 100 26.5 [8.0, 45.5] 80 42.0 [30.0, 65.5] 93 38.0 [13, 60] 68 40.0 [15.5, 52.5]
Lunch (g) 100 38.5 [20.5, 60] 80 58.0 [37.5, 78] 93 55.0 [28, 75] 68 44.0 [23, 69.5]
Dinner (g) 100 130.0 [118, 143.5] 80 137.0 [124.5, 148.5] 93 132.0 [120, 147] 68 134.0 [121, 147]
Exercise status 100 82 93 64
None 54 54% 24 29% 35 38% 27 42%
1-3 day(s)/ wk 19 19% 14 17% 16 17% 7 11%
4 days or over/ wk 27 27% 44 54% 42 45% 30 47%
Exercise status: change from baseline 82 62
Less 9 11% 13 20%
Not change 43 52% 40 63%
More 30 37% 11 17%
Dada are mean (SD), Median [25%tile, 75%tile], or number (%).
* SD: standard deviation.
# Value of HbA1C is JDS
15.
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intake by meal for type 2 diabetes patients in primary
care clinics successfully registered 193 participants. The
ITT/LOCF analysis to compare the mean changes at
6 months from baseline in the HbA1c level showed a
significantly greater reduction in the IG compared to
the CG (−0.5%, p = 0.004). The sensitivity analyses by
baseline adjusted analyses of PPA/CDS and ITT/MI
showed similarly significant effectiveness. In the analyses
of dietary intake, compared with the CG, in the IG energy
intake at dinner decreased significantly from baseline and
vegetable intake significantly increased for the whole day,
breakfast, and lunch in the all models. These results wereconfirmed by several sensitivity analyses, whereas statis-
tical significance was not shown for the other clinical and
dietary outcome measures. These results suggested that
the structured individual-based lifestyle education by
registered dietitians for glycemic control in primary care
settings has the potential to improve HbA1c levels in pa-
tients with type 2 diabetes.
To encourage reduction in energy intake at dinner
and increase in vegetable intake at breakfast and lunch
is useful in lowering the HbA1c level to improve gly-
cemic control with type 2 diabetes patients not only in
Japan but also in other countries. Furthermore, although
not significant, the proportion of patients achieving the
Table 3 Mean change at 6th months from baseline in clinical data
Intervention Control Model 1 (crude) Model 2 (adjusted) Model 3 (adj ted) Model 4 (adjusted)
Mean ± SE Mean ± SE Difference 95%CI p-value Difference 95%CI p-value Differences 95% p-value Difference 95%CI p-value
HbA1c(%)
#
LOCF1) −0.7 ± 0.1 −0.2 ± 0.1 −0.5 (−0.8 to −0.2) 0.004 −0.5 (−0.8 to −0.2) 0.004 −0.5 (−0.8 to .2) 0.003 −0.5 (−0.9 to −0.1) 0.011
CDS2) −0.7 ± 0.1 −0.2 ± 0.1 −0.5 (−0.9 to −0.1) 0.009 −0.4 (−0.8 to −0.1) 0.014 −0.5 (−0.1 to .8) 0.013 −0.5 (−1.0 to −0.1) 0.028
MI3) −0.7 ± 0.1 −0.3 ± 0.1 −0.5 (−0.9 to −0.1) 0.030 −0.4 (−0.8 to −0.1) 0.041 −0.4 (−0.8 to .2) 0.045 −0.4 (−0.6to −0.0) 0.045
BMI(kg/m2)
LOCF1) −0.5 ± 0.1 −0.3 ± 0.2 −0.2 (−0.7 to 0.2) 0.351 −0.1 (−0.6 to 0.4) 0.598 −0.1 (−0.6 to 3) 0.548 −0.3 (−0.8 to 0.2) 0.221
CDS2) −0.6 ± 0.2 −0.3 ± 0.2 −0.3 (−0.8 to 0.1) 0.146 −0.2 (−0.8 to 0.3) 0.331 −0.3 (−0.8 to 3) 0.297 −0.3 (−0.9 to 0.2) 0.216
MI3) −0.5 ± 0.1 −0.3 ± 0.2 −0.2 (−0.7 to 0.2) 0.351 −0.1 (−0.7 to 0.5) 0.693 −0.1 (−0.7 to 4) 0.633 −0.1 (−0.6 to 0.5) 0.829
FPG(mg/dl)
LOCF1) −19 ± 8 −20 ± 8 1 (−23 to 25) 0.919 8 (−11 to 28) 0.367 9 (−11 to ) 0.347 22 (−10 to 54) 0.165
CDS2) −20 ±10 10 −14 ± 11 7 (−37 to 23) 0.633 1 (−23 to 25) 0.933 0 (−25 to ) 0.993 5 (−33 to 43) 0.792
MI3) $
SBP(mmHg)
LOCF1) −1 ± 3 0 ± 3 1 (−9 to 7) 0.748 −1 (−7 to 6) 0.802 0 (−7 to 0.963 0 (−8 to 8) 0.951
CDS2) −1 ± 3 −2 ± 3 1 (−7 to 9) 0.804 2 (−5 to 9) 0.514 4 (−4 to 0.416 4 (−5 to 12) 0.370
MI3) −1 ± 3 −2 ± 3 −1 (−9 to 7) 0.738 −2 (−8 to 5) 0.593 −2 (−9 to 0.523 −3 (−11 to 4) 0.368
DBP(mmHg)
LOCF1) −1 ± 1 −3 ± 2 1 (−3 to 6) 0.560 −3 (−1 to 7) 0.164 −2 (−2 to 0.239 4 (−1 to 8) 0.088
CDS2) −0 ± 1 −4 ± 1 3 (−1 to 7) 0.159 4 (−0 to 8) 0.050 4 (−0 to 0.073 5 (0 to 10) 0.049
MI3) −1 ± 1 −3 ± 2 −2 (−7 to 2) 0.296 −3 (−8 to 1) 0.120 −3 (−8 to 0.166 −3 (−8 to 2) 0.171
LDL(mg/dl)
LOCF1) −5 ± 2 −1 ± 2 −4 (−10 to 3) 0.286 −2 ( −8 to 3) 0.387 −3 (−10 t ) 0.245 −4 (−13 to 5) 0.344
CDS2) −4 ± 2 0 ± 3 −4 (−12 to 3) 0.241 −3 (−10 to 4) 0.371 −4 (−11 t ) 0.252 −5 (−16 to 5) 0.283
MI3) −5 ± 4 2 ± 4 7 ( 2 to 12) 0.198 6 ( 0 to 10) 0.250 7 (−4 to ) 0.196 7 (−6 to 18) 0.223
HDL(mg/dl)
LOCF1) −1 ± 1 1 ± 1 −0 (−4 to 3) 0.823 −0 (−4 to 3) 0.863 0 (−3 to 0.861 2 (−3 to 8) 0.393








































Table 3 Mean change at 6th months from baseline in clinical data (Continued)
Triglycerides
(mg/dl)
LOCF1) −3 ± 8 −5 ± 9 2 (−23 to 26) 0.894 4 (−20 to 28) 0.748 2 (−22 to 27) 0.239 7 (−28 to 43) 0.667
CDS2) −7 ± 8 −5 ± 9 −3 (−29 to 24) 0.833 4 (−27 to 25) 0.951 −5 (−31 to 22) 0.708 −1 (−38 to 36) 0.953
MI3) $
SE: standard error, 95%CI: 95% confidence interval, degree of freedom = 18.
# Value of HbA1C is JDS
15.
1) LOCF: last observation carried forward (IG: n = 100, CG: n = 93).
2) CDS: complete data set. (IG: n = 84), CG: n = 70).
3) MI: Multiple imputation with all analysed variables (number of imputations = 200) (IG: n = 100, CG: n = 93).
Model 1: crude.
Model 2: mixed model adjusted for baseline.
Model 3: mixed model adjusted for baseline, gender, age and BMI.
Model 4: mixed model adjusted for baseline, gender, age, BMI, smoking status, exercise status, change of exercise level, family history of type 2 diabetes, and complication.



















Table 4 Mean change at 6th months from baseline in dietary data
Intervention Control Model 1 (crude) Model 2 (adjusted) Model 3 (adju ) Model 4 (adjusted)
Mean ± SE Mean ± SE Difference 95%CI p-value Difference 95%CI p-value Difference 95%CI p-value Difference 95%CI p-value
Energy intake-whole day (kcal)
LOCF1) −29 ± 16 −7 ± 17 −22 (−23 to 67) 0.364 −21 (−19 to 61) 0.333 −23 (−18 to 6 0.283 −27 (−112 to 9) 0.222
CDS2) −54 ± 22 9 ± 24 −54 (−10 to 117) 0.114 −50 (− 1 to 108) 0.085 −54 (− 1 to 1 0.073 −53 (−151 to −12) 0.034
MI3) −54 ± 35 −20 ± 38 −34 (−76 to 145) 0.519 −33 (−68 to 134) 0.493 −39 (−62 to 1 0.420 −52 (−159 to 50) 0.321
Energy intake-breakfast (kcal)
LOCF1) 19 ± 11 10 ± 12 8 (−41 to 24) 0.619 11 (−41 to 19) 0.480 11 (−41 to 2 0.505 12 (−56 to 32) 0.598
CDS2) 17 ± 15 23 ± 17 6 (−39 to 51) 0.793 2 (−43 to 38) 0.909 0 (−42 to 4 0.986 2 (−50 to 55) 0.922
MI3) 1 ± 22 5 ± 24 −5 (−59 to 68) 0.891 0 (−65 to 64) 0.988 −3 (−61 to 6 0.937 2 (−72 to 62) 0.888
Energy intake-lunch (kcal)
LOCF1) −6 ± 10 −6 ± 10 0 (−28 to 29) 0.974 −1 (−26 to 27) 0.965 −3 (−24 to 3 0.829 22 (−17 to 62) 0.567
CDS2) −13 ± 13 −2 ± 14 −11 (−27 to 49) 0.570 −11 (−27 to 49) 0.551 −13 (−23 to 4 0.488 −34 (−13 to 82) 0.178
MI3) −16 ± 21 −12 ± 22 −3 (−56 to 64) 0.899 −6 (−48 to 58) 0.808 −11 (−41 to 6 0.694 −24 (−34 to 80) 0.441
Energy intake-dinner (kcal)
LOCF1) −23 ± 6 −4 ± 6 −19 (−35 to −3) 0.031 −19 (−35 to −2) 0.040 −19 (−35 to − 0.030 −29 (−48 to −10) 0.007
CDS2) −29 ± 7 2 ± 8 −31 (−51 to −11) 0.008 −31 (−51 to −11) 0.007 −37 (−58 to − 0.003 −41 (−61 to −20) 0.001
MI3) −30 ± 10 −7 ± 11 −23 (−51 to 5) 0.136 −22 (−50 to 6) 0.147 −24 (−50 to 0.110 −24 (−54 to 4) 0.114
Proportion of carbohydrate to total energy intake (%)
LOCF1) 0.0 ± 0.3 0.6 ± 0.4 0.6 (−0.4 to 1.6) 0.246 0.7 (−0.3 to 1.6) 0.193 0.6 (−0.3 to 1 0.205 0.2 (−1.0 to 1.3) 0.768
CDS2) 0.0 ± 0.4 −0.5 ± 0.4 0.4 (−0.6 to 1.5) 0.373 0.4 (−0.5 to 1.3) 0.390 0.3 (−0.5 to 1 0.438 −0.3 (−1.1 to 0.6) 0.559
MI3) −0.1 ± 0.7 0.0 ± 0.7 0.2 (−2.0 to 2.0) 0.883 0.0 (−2.0 to 2.1) 0.985 −0.1 (−1.8 to 2 0.945 −0.3 (−1.7 to 2.3) 0.764
Proportion of protein to total energy intake (%)
LOCF1) 0.2 ± 0.1 0.2 ± 0.1 0.0 (−0.3 to 0.3) 0.837 0.0 (−0.4 to 0.3) 0.764 0.1 (−0.4 to 0 0.759 0.1 (−0.3 to 0.5) 0.633
CDS2) 0.3 ± 0.1 0.3 ± 0.1 0.0 (−0.4 to 0.4) 0.999 0.0 (−0.4 to 0.3) 0.862 0.0 (−0.4 to 0 0.884 0.2 (−0.1 to 0.6) 0.257
MI3) 0.3 ± 0.2 0.1 ± 0.2 −0.2 (−0.9 to 0.5) 0.512 −0.2 (−0.8 to 0.5) 0.546 −0.2 (−0.8 to 0 0.597 −0.3 (−0.3 to 0.6) 0.825
Proportion of total fat to total energy intake (%)
LOCF1) −0.2 ± 0.3 0.3 ± 0.3 −0.6 (−1.3 to 0.1) 0.152 −0.6 (−1.3 to 0.1) 0.111 −0.6 (−1.2 to 0 0.110 −0.3 (−1.2 to 0.5) 0.435
CDS2) −0.2 ± 0.3 0.2 ± 0.3 −0.5 (−1.3 to 0.4) 0.282 −0.4 (−1.1 to 0.3) 0.287 −0.3 (−0.9 to 0 0.307 0.1 (−0.6 to −0.7) 0.861
MI3) −0.2 ± 0.6 −0.2 ± 0.6 0.0 (−1.9 to 1.8) 0.755 −0.1 (−1.5 to 1.6) 0.941 0.0 (−1.4 to 1 0.953 0.1 (−1.6 to 1.4) 0.900
Vegetable intake-whole day (g)
LOCF1) 35.1 ± 5.5 −0.2 ± 5.7 35.3 (19.6 to 50.6) 0.000 29.0 (14.9 to 43.1) 0.001 28.6 (14.3 to 4 0.001 25.5 (5.9 to 45.1) 0.021
CDS2) 43.2 ± 6.3 5.4 ± 7,1 37.8 (19.2 to 56.4) 0.001 31.4 (13.2 to 49.6) 0.003 30.1 (11.6 to 4 0.005 28.6 (8.9 to 48.2) 0.011











































Table 4 Mean change at 6th months from baseline in dietary data (Continued)
Vegetable intake-breakfast (g)
LOCF1) 16.0 ± 2.8 −0.3 ± 2.8 16.3 (8.6 to 23.9) 0.001 13.0 (5.9 to 20.0) 0.002 12.7 (6.5 to 18.9 0.001 14.3 (4.6 to 23.7) 0.001
CDS2) 20.2 ± 3.0 0.8 ± 3.3 19.4 (10.5 to 28.3) 0.000 14.1 (6.3 to 21.9) 0.003 13.1 (5.3 to 20.9 0.004 11.5 (1.1 to 21.5) 0.043
MI3) 15.5 ± 4.2 −0.5 ± 4.5 16.0 (3.9 to 28.3) 0.021 13.0 (−0.3 to 22.5) 0.078 12.7 (−0.2 to 21.3 0.079 12.5 (−0.3 to 22.7) 0.062
Vegetable intake-lunch (g)
LOCF1) 13.1 ± 3.0 0.5 ± 3.1 9.5 (4.2 to 21.0) 0.009 9.9 (2.2 to 16.9) 0.020 9.0 (1.7 to 16.4 0.027 6.0 (4.3 to 16.2) 0.270
CDS2) 15.9 ± 3.4 5.1 ± 3.8 10.8 (10.8 to 20.8) 0.048 8.5 (−0.4 to 17.5) 0.078 8.0 (−1.2 to 17.2 0.108 3.6 (−8.0 to 15.1) 0.550
MI3) 15.0 ± 4.5 −0.3 ± 4.9 15.3 (0.6 to 30.0) 0.042 10.9 (−2.3 to 24.1) 0.113 10.5 (−1.3 to 22.2 0.106 9.8 (−2.1 to 21.7) 0.134
Vegetable intake-dinner (g)
LOCF1) 6.4 ± 2.8 −0.6 ± 2.9 7.2 (−0.8 to 14.8) 0.095 5.8 (−1.5 to 13.1) 0.129 5.6 (−1.7 to 12.9 0.144 4.2 (−4.8 to 13.3) 0.376
CDS2) 5.7 ± 3.1 0.1 ± 3.4 5.6 (−0.8 to 16.9) 0.093 6.0 (−2.4 to 14.9) 0.177 6.2 (−14.3 to 45. 0.174 3.1 (−5.9 to 45.1) 0.491
MI3) 8.3 ± 3.9 −1.3 ± 4.3 9.7 (−3.4 to 19.8) 0.132 8.2 (−3.4 to 19.8) 0.186 8.0 (−4.6 to 20.7 0.196 8.2 (−3.8 to 20.2) 0.205
Dietary fiber intake (g)
LOCF1) 0.7 ± 0.2 0.1 ± 0.2 0.6 (0.1 to 1.0) 0.022 0.5 (0.1 to 0.9) 0.039 0.5 (−0.1 to 1.0 0.051 0.4 (0.0 to 1.0) 0.241
CDS2) 0.9 ± 0.2 0.3 ± 0.2 0.6 (0.0 to 1.2) 0.087 0.4 (−0.1 to 1.0) 0.157 0.4 (−0.2 to 1.0 0.225 0.3 (−0.5 to 1.0) 0.489
MI3) 0.7 ± 0.3 0.1 ± 0.3 0.6 (−1.6 to 0.4) 0.246 0.4 (−1.4 to 0.5) 0.346 0.4 (−1.4 to 0.6 0.380 0.4 (−1.3 to 0.6) 0.393
SE: standard error, 95%CI: 95% confidence interval, degree of freedom = 18.
# Value of HbA1C is JDS
15.
1) LOCF: last observation carried forward (IG: n = 100, CG: n = 93).
2) CDS: complete data set. (IG: n = 84, CG: n = 70).
3) MI: Multiple imputation with all analyzed variables (number of imputations = 200) (IG: n = 100, CG: n = 93).
Model 1: crude.
Model 2: mixed model adjusted for baseline.
Model 3: mixed model adjusted for baseline, gender, age and BMI.




























































Figure 2 Mean change with standard error at 6 months from
baseline in vegetable intake (g).
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http://www.biomedcentral.com/1471-2458/13/467recommended clinical target for HbA1c (<6.9%) [10] was
greater in the IG (45%) than in the CG (29%).
Although mean changes between the two groups were
not significant for BMI, this might be an understandable
result considering that ‘normal’ BMI range for Asians is
less than other groups of Europeans and Americans [19,20],
and thus are at risk of developing type 2 diabetes patients
at a lower BMI. Asking patients who have already reduced
total energy intake to some extent, even though not to a
sufficient extent, to make further reductions may be not
feasible and usually results in low compliance. This is
particularly so in patients who are aware of their limita-
tions for weight control or who are not obese and there-
fore have a moderate energy intake. To change the way
of eating at dinner and to recommend eating more veg-
etables may bring about greater compliance for partici-
pants whether or not they are obese. In turn, our dietary
education by modifying dietary intake according to meals
and encouraging vegetable intake has the probability of
being effective in Asian patients who are not obese. In
Japan, lifestyle education by registered dietitians for dia-
betes patients is provided mainly in hospitals and in
only a few clinics. Dietary lifestyle education is import-
ant for many of type 2 diabetes patients. To conduct a
system for effective dietary lifestyle education in clinics
should be considered to be warranted in Japan.
Comparison with other studies
The clinical effectiveness of several medical nutrition ther-
apies for diabetes has been reported [21,22]. Research is
increasingly demonstrating that medical nutrition therapy
administered by a registered dietitians or nutrition profes-
sional is a key component of diabetes management and
complements treatment of diabetes by physicians [22].
Considering results from past studies [5,6,16,23–32], it
is important for effective glycemic control 1) that pa-
tients be given results of nutritional assessments so that
meals can be modified [5,6,16], 2) that a registered dietitianprovides support to patients in establishing reasonable
goals [5,6,16,23,26,28], and 3) that patients be given con-
tinuous support in behavior modification [5,6,23-32].
Because medical doctors usually do not have the time
for nutritional education, support by co-medical staff
members such as registered dietitians is important to
bring successful nutritional education to fruition. Actu-
ally, several randomized controlled trials examining the
effects of long-term lifestyle education by co-medical
staff, including dietary education, resulted in success in
decreasing HbA1c levels [6,23,26,27,31]. Studies [23,27,31]
with baseline HbA1c levels (7.3% to 7.7%) similar to ours
(7.5%) showed an effect size for the mean change from
baseline of −0.7%, -0.5%, and −0.1%, respectively, which
did not differ largely from our result of −0.5%.
Because excessive eating at night increases insulin re-
sistance [35], the SILE program aimed to improve FPG
by reducing energy intake at dinner and to improve post-
meal plasma glucose by increasing vegetable intake at
breakfast and lunch and increasing dietary fiber intake.
It is known that targeting both postprandial plasma glu-
cose and FPG is an important strategy for achieving
optimal glycemic control [36]. The SILE program is
characterized as having a target that can be continued
by the participant and that would improve both FPG
and postprandial plasma glucose levels.
Strengths and limitations of the study
Studies on lifestyle interventions in individuals with type 2
diabetes have been performed in recent years, including
those with individual randomization [5,6,23,24,26-29,31]
and cluster randomization designs [25,30,32-34,37,38]. It
must be considered that in clinic-based studies there is
the possibility of contamination bias between intervention
and control participants in the same clinic [39]. Thus, a
cluster randomization design would eliminate this possi-
bility. To our knowledge, this is the first cluster random-
ized study to evaluate structured individual-based lifestyle
education in a community setting over a 6-month treat-
ment period in Japan.
To modify behavior with regard to dietary intake, an indi-
vidualized approach is required in addition to information
on appropriate dietary content. In this study, we could re-
view in detail a patient’s dietary habits using the FFQW82
and graphs, which helped patients to recognize their nutri-
tional problems and decide what problem-solving and goal-
setting strategies could be implemented. This may have
successfully resulted in reduced energy intake at dinner and
increased vegetable intake at breakfast and lunch and an
improvement in the HbA1c level in the IG.
As to whether plasma glucose was more often moni-
tored in the IG than in the CG, there is little possibility
of increased monitoring in the IG. In Japan, almost all
patients who use insulin are likely to use home glucose
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http://www.biomedcentral.com/1471-2458/13/467monitoring, however, the proportions of patients using
insulin were similar (around 10%) in each group, which
could eliminate a significant bias.
There are some limitations in this study design. Firstly,
only patients were blinded to the assignment of educa-
tion. In order to avoid selection bias, we asked general
practitioners to recruit all the patients in turn. Further-
more, the low number of registered patients in the CG
was mainly because of an extended sick leave of a gen-
eral practitioner in charge of one clinic and the inclusion
of a newly started clinic (enrollment of 10 patients, re-
spectively). Therefore, the potential selection bias may
be slight.
Secondly, the dropout rates were relatively small; 20%
for the IG and 25% for the CG. Because our study was
based on usual clinical situations, patients were expected
to visit their clinics every 2 or 3 months, and we did not
anticipate a large number of dropouts. Even though the
protocol required enrollment of 10 patients per clinic,
we permitted enrollment of 7–13 patients per clinic to
allow for dropouts so that statistical power could be
maintained and to take into account a shortfall in enroll-
ment in some clinics. Furthermore, we conducted multiple
imputation analyses to examine the effect of dropouts on
the results.
General practitioners were randomly assigned to either
the IG or CG, and general practitioners were permitted
to follow their usual clinical practices. Changes in medi-
cines by the participants were not numerous and pro-
portions of these changes were not largely different
between the IG and CG (n = 7; 7.0% and n = 11; 11.8%,
respectively. See Figure 1). We cannot deny the possibility
that the general practitioners of patients with less than
optimal glycemic control might have changed the dia-
betes medication of some of these patients during the
study period, which would bring about a bias. However,
changes in diabetes medication are inevitable in the
management of patients with less than optimal glycemic
control. In order to examine this point, we added a sen-
sitivity analysis that included 18 patients whose medica-
tions were changed during the study period. Thus, PPA
included 172 patients (91 [91%] IG, 81 [87%] CG). The
results were almost concordant with results shown for
patients who did not have changes in medication during
the study period. In addition, none of the patients used
dietary fiber pills as a supplement; however, 4 patients
took a tea that was considered a health food to maintain
postprandial glucose (2 for IG and 2 for CG). This
would not seem to affect vegetable intake.
Thirdly, the success of this program was to some de-
gree dependent on the skills of the dietitians involved.
To address this issue, we developed a training process
for the registered dietitians before the start of the
randomization study. Education in implementing theprogram was therefore important. Furthermore, the as-
sessment sheet with items ranked according to priority
helped standardize advice by the registered dietitians.
Training for the registered dietitians was conducted based
on an instruction manual and thus did not differ between
dietitians at the intervention clinics and the control
clinics. Although the effects were somewhat varied among
the dietitians, the variability among those assigned to the
IG and CG was similar. Furthermore, we mentioned that
five registered dietitians were in charge of both groups.
However, because the dietitians were trained to give ad-
vice following the manual, the possibility of contamination
of advice was less likely. As for advice on activity, the IG
had received more practical advice compared to the CG.
In fact, 37% of the IG responded that they had performed
more exercise compared to the CG (17%). Therefore,
not only dietary education but also practical advice on
activity might have affected the results. However, our
results showed an improvement in dietary intakes, and
it is natural to make the interpretation that improve-
ment in dietary intakes resulted in improvements in
plasma glucose levels.
Fourthly, in order to improve glycemic control, main-
taining long-term control is required. An earlier assess-
ment could be biased as a result of changes made only
because subjects were conscious of being studied. The
follow-up period in this study was 6 months. However,
further study is warranted.
Implication
In the past, simple lifestyle education for patients with
type 2 diabetes was conducted by a general practitioner
or clinical nurse in community medical settings while
providing medical care. Although dietary education by
registered dietitians has been increased by degrees, continu-
ous evidence-based lifestyle education should be warranted.
Active utilization of dietitians as co-medical staff can help
in successfully providing diabetes care in community medi-
cine. This study provides some evidence for the value of
structured individual-based lifestyle education for glycemic
control by registered dietitians in primary care settings. The
result will be useful to encourage lowering HbA1c and it
may help to improve glycemic control not only in Japan
but also in other countries.
Conclusions
The dietitians delivered structured individual-based life-
style education for glycemic control in primary care set-
tings resulted in significantly improved HbA1c levels in
the participants with type 2 diabetes. These results will
provide useful information to not only Japanese type 2
diabetes patients but also to other Asian type 2 diabetes
patients as well as non-obese type 2 diabetes patients in
Western countries.
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